Arbutus Biopharma News

Arbutus Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Whitefort Capital Master Fund, LP(6.8%),Whitefort Capital GP, LLC(6.8%), etc.

May 17 09:07 ET

Arbutus Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Whitefort Capital Master Fund, LP(6.8%),Whitefort Capital GP, LLC(6.8%), etc.

May 9 08:02 ET

Arbutus Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Whitefort Capital Management, LP(7.9%),David Salanic(7.9%), etc.

Feb 14 16:46 ET

Arbutus Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Two Seas Capital LP(5.4%),Two Seas Capital GP LLC(5.4%), etc.

Feb 14 10:52 ET

Arbutus Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.2%)

Feb 12 09:44 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Naftzger J. Christopher

Feb 5 19:59 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sims Karen

Feb 5 19:59 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer HASTINGS DAVID C

Feb 5 19:59 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sofia Michael J.

Feb 5 19:58 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer McElhaugh Michael J.

Feb 5 19:58 ET

Arbutus Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Two Seas Capital LP(5.7%),Two Seas Capital GP LLC(5.7%), etc.

Nov 21, 2023 08:00 ET

Arbutus Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Whitefort Capital Management, LP(6.0%),David Salanic(6.0%), etc.

Sep 11, 2023 17:07 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Rewolinski Melissa

Jul 13, 2023 16:13 ET

Arbutus Biopharma | 3: Initial statement of beneficial ownership of securities-Director Rewolinski Melissa

Jul 13, 2023 16:11 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sims Karen

Jul 12, 2023 16:50 ET

Arbutus Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Sims Karen

Jul 12, 2023 16:48 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Naftzger J. Christopher

Jul 12, 2023 16:12 ET

Arbutus Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Naftzger J. Christopher

Jul 12, 2023 16:10 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director HENRIQUES RICHARD C JR

May 26, 2023 16:27 ET

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director BURGESS DANIEL D

May 26, 2023 16:22 ET